LOGIN
AAOS2018: Two-year results favour ECRB release versus PRP injection for lateral epicondylitis
March 2018
AAOS2018: Two-year results favour ECRB release versus PRP injection for lateral epicondylitis
Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A
Arthroscopic Debridement Versus Platelet-Rich Plasma Injection: A Prospective, Randomized, Comparative Study of Chronic Lateral Epicondylitis With a Nearly Two-Year Follow Up
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
101 patients with lateral epicondylitis were randomized to either arthroscopic release of the extensor carpi radialis brevis or to platelet-rich plasma injections. Patients were assessed for pain, function, and grip strength over 104-week follow-up. While 8-week results for grip strength significantly favoured the PRP group compared to the arthroscopy group, 104-week results for pain, function, an...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.